News Focus
News Focus
Followers 20
Posts 8442
Boards Moderated 5
Alias Born 10/17/2022

Re: None

Tuesday, 01/27/2026 8:56:57 AM

Tuesday, January 27, 2026 8:56:57 AM

Post# of 475
$BCTX Furthers Advancements with encouraging Phase 2 progress in metastatic breast cancer. 9 patients remain alive 18 to 47 months post enrollment, well beyond typical benchmarks.

READ THE NEWS: https://www.globenewswire.com/news-release/2026/01/27/3226377/0/en/BriaCell-Highlights-Extended-18-47-Months-Survival-in-Phase-2-Metastatic-Breast-Cancer-Patients.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCTX News